Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.
Meister TL, Gottsauner JM, Schmidt B, Heinen N, Todt D, Audebert F, Buder F, Lang H, Gessner A, Steinmann E, Vielsmeier V, Pfaender S, Cieplik F. Meister TL, et al. Among authors: vielsmeier v. Virus Res. 2022 Jul 15;316:198791. doi: 10.1016/j.virusres.2022.198791. Epub 2022 May 2. Virus Res. 2022. PMID: 35504446 Free PMC article. Clinical Trial.
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2.
Gottsauner MJ, Michaelides I, Schmidt B, Scholz KJ, Buchalla W, Widbiller M, Hitzenbichler F, Ettl T, Reichert TE, Bohr C, Vielsmeier V, Cieplik F. Gottsauner MJ, et al. Among authors: vielsmeier v. Clin Oral Investig. 2020 Oct;24(10):3707-3713. doi: 10.1007/s00784-020-03549-1. Epub 2020 Sep 2. Clin Oral Investig. 2020. PMID: 32876748 Free PMC article.
Efficacy of a Mouthwash Containing CHX and CPC in SARS-CoV-2-Positive Patients: A Randomized Controlled Clinical Trial.
Bonn EL, Rohrhofer A, Audebert FX, Lang H, Auer DL, Scholz KJ, Schuster P, Wenzel JJ, Hiller KA, Buchalla W, Gottsauner JM, Vielsmeier V, Schmidt B, Cieplik F. Bonn EL, et al. Among authors: vielsmeier v. J Dent Res. 2023 Jun;102(6):608-615. doi: 10.1177/00220345231156415. Epub 2023 Mar 21. J Dent Res. 2023. PMID: 36942423 Free PMC article. Clinical Trial.
Prevalence of acute olfactory dysfunction differs between variants of SARS-CoV-2-results from chemosensitive testing in wild type, VOC alpha (B.1.1.7) and VOC delta (B.1617.2).
Hintschich CA, Vielsmeier V, Bohr C, Hagemann J, Klimek L. Hintschich CA, et al. Among authors: vielsmeier v. Eur Arch Otorhinolaryngol. 2022 Nov;279(11):5445-5447. doi: 10.1007/s00405-022-07431-6. Epub 2022 Jun 29. Eur Arch Otorhinolaryngol. 2022. PMID: 35767061 Free PMC article.
TIMolol nasal spray as a treatment for epistaxis in hereditary hemorrhagic telangiectasia (HHT) - Study protocol of the prospective, randomized, double-blind, controlled cross-over TIM-HHT trial.
Andorfer KEC, Seebauer CT, Koller M, Zeman F, Berneburg M, Fischer R, Vielsmeier V, Bohr C, Kühnel TS. Andorfer KEC, et al. Among authors: vielsmeier v. Clin Hemorheol Microcirc. 2022;80(3):307-315. doi: 10.3233/CH-211253. Clin Hemorheol Microcirc. 2022. PMID: 34864649
80 results